Prevalence and Factors Influencing Sarcopenia Among Community-Dwelling Older Adults Using the Asian Working Group for Sarcopenia Definition

Abstract

Objective This study aimed to explore the prevalence and impact of related factors for sarcopenia among community-dwelling older people in Chongming district, China, according to the diagnostic criteria of the Asia Working Group for Sarcopenia-2019. Methods We conducted a cross-sectional study from April 2021 to December 2021. Diagnosis of sarcopenia (non-sarcopenia, possible sarcopenia, sarcopenia, and severe sarcopenia) was based on appendicular skeletal muscle mass index, handgrip strength, gait speed, and the 5-time chair stand test. Staff collected all subjects’ clinical and sociodemographic characteristics, cardiovascular disease (CVD) risk factors, inflammatory markers, physical activity (PA), and daily lifestyle activities to identify sarcopenia-related factors. Results A total of 1407 older people aged ≥ 65 years were enrolled into the study (58.7% female). The prevalence of confirmed sarcopenia was 19.6% (17.1% in females and 23.1% in males). The prevalence of possible sarcopenia, sarcopenia, and severe sarcopenia were 19.7% (22.2% in females, 16.2% in males), 11.9% (10.1% in females, 14.5% in males), and 7.7% (7% in females, 8.6% in males), respectively. Increasing age, gender, depression status, and high-fat mass were associated with an increased likelihood of sarcopenia in all subjects. In females, living alone, high-fat mass, lower body mass index (BMI), lower body weight, and have no time spent doing housework increased the likelihood of sarcopenia. In males, depression status, high-fat mass, higher neutrophils-to-lymphocytes ratio (NLR), lower BMI, lower body weight increased the likelihood of sarcopenia. Conclusion Our study showed a high prevalence of sarcopenia among community-dwelling older people in the Chongming district. Detection, prevention, and treatment efforts are needed to reduce the impact of sarcopenia in older, rural communities in China.

Análisis de la relación entre sarcopenia y síntomas depresivos en adultos mayores: una revisión de alcance

“…(Z. Chen et al, 2022;Cheng et al, 2021;Darroch et al, 2022;de Souza et al, 2021;Delibaş et al, 2021;Gao et al, 2021;He et al, 2022;Jin et al, 2021;Kirk et al, 2021;Kitamura et al, 2020;Kurita et al, 2021;Lee & Lee, 2023;Lin et al, 2022;Lu et al, 2023;Nunes et al, 2021;Suzan et al, 2022;Tan et al, 2022;Zhang et al, 2022). En la tabla 1 se muestran las características y principales resultados de los estudios que incluyeron un análisis transversal.…”

“…Por su parte, en las investigaciones realizadas por Chen et al (2022), de Souza et al (2021, He et al (2022), Kitamura et al (2020) y Kurita et al (2021), se observó que la prevalencia de sarcopenia era significativamente mayor en el grupo de adultos mayores con síntomas depresivos, en comparación con el grupo sin depresión, reportando los momios en un rango de 1.68 a 2.65.…”

Cross-Cultural Adaptation and Validation of the Portuguese Version of the SARC-F in Community-Dwelling Older Adults

“…For instance, Liu et al [ 42 ] found that, in Chinese adults ≥ 50 years, the prevalence of sarcopenia according to different operational definitions were 11.8% (EWGSOP2), 18.1% (FNIH), 22.8% (AWGS 2019), 24.1% (IWGS), and 57.1% (EWGSOP1). However, there are other factors such as age group, gender, geographical areas, ethnicities, or locations that may affect the prevalence of sarcopenia [ 43 , 44 ]. A meta-analysis published by Petermann-Rocha et al [ 45 ] described that the prevalence of sarcopenia varied from 10% to 27% in adults aged 60 years and over, where the highest prevalence was found in Oceania (EWGSOP1) and the lowest in Europe (EWGSOP2).…”

Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer

“…SMI was calculated by dividing the CSA, measured at the C3 vertebra level on CT scans by the square of the patient's height in meters 24 . Subjects with SMI < 41 cm 2 /m 2 in females, <43 cm 2 /m 2 in underweight or healthy weight males, and <53 cm 2 /m 2 in overweight or obese males were considered sarcopenic for the purposes of this study 25‐31 …”

“…24 Subjects with SMI < 41 cm 2 /m 2 in females, <43 cm 2 /m 2 in underweight or healthy weight males, and <53 cm 2 /m 2 in overweight or obese males were considered sarcopenic for the purposes of this study. [25][26][27][28][29][30][31]…”